Our analysis also highlights significant correlations between CD47 expression and clinicopathologic features, including age (≥ 60 years old), TNM staging, lymph node metastasis, tumor differentiation, and tumor recurrence, providing new insights into the prognostic value of CD47. Here, CD47 is linked to neoplasm.